This report was reuploaded on July 22, 2021, to update a data point in the chart on page 17.
Revisiting our 2021 US VC predictions
At the start of the year, PitchBook analysts made a raft of predictions about how the venture capital market would fare in 2021. Six months into the year, the crystal ball is becoming clearer, and our latest analyst note updates the scorecard.
Takeaways include
- Biotech and pharma did not disappoint our forecast that the sector would notch $20 billion in deal value for the second year in a row. In fact, it did so in just six months.
- We expected SPAC IPO activity to decline this year, and it did—but only after exploding in the first quarter with 281 SPAC IPOs.
- Nontraditional investors are on pace to lead nearly 2,000 early- and late-stage deals this year, which would surpass our prediction of a record 1,600 deals.